Menu

Summit Therapeutics Inc. SMMT

Full chart Compare
Set alert

Price alert · SMMT

All alert types
16.64 USD -1.19 (-6.67%)

At closeNov 11, 2026, 7:56 PM EST

16.70 +0.06 +0.36%

After hours · Nov 11, 7:56 PM ET

16.59 Day range 17.91
12.07 52-week range 29.23
YTD
-4.86%
1 year
-13.15%

Revenue & Expenses

Other Operating Income → Expenses: $5.95MExpenses → Selling, General & Admin: $26.74MExpenses → Research & Development: $52.00MExpenses → Interest Expense: $5.32MExpenses → Other Expenses: $1.37MGross Profit → Expenses: $705.00KRevenue → Gross Profit: $705.00KNet Loss → Expenses: $78.78MOther Operating Income$5.95MGross Profit$705.00KNet Loss$78.78MExpenses$85.44MSelling, General & Admin$26.74MResearch & Development$52.00MInterest Expense$5.32MOther Expenses$1.37MRevenue$705.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

SMMT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.09B226.00M609.65M72.79M88.00M
537.67M150.78M59.47M52.00M85.35M
556.75M60.21M29.26M26.74M23.61M
-1.09B-226.00M-609.65M-72.09M-86.19M
-1.08B-221.31M-614.93M-78.78M-88.60M
-1.08B-221.31M-614.93M-78.78M-88.60M
-1.08B-221.31M-614.93M-78.78M-88.60M
-1.08B-221.31M-614.93M-78.78M-88.60M
-1.44-0.31-0.99-0.41-0.67
-1.44-0.31-0.99-0.41-0.67
-1.44-0.31-0.99-0.41-0.67
-1.08B-212.63M-598.47M-74.38M-88.60M
-1.08B-212.63M-598.47M-74.38M-88.60M
747.70M718.54M619.65M193.34M131.71M
747.70M718.54M619.65M193.34M131.71M